N.H. Code Admin. R. He-P 4035.12
Mobile Medical Service Administrative Requirements
Effective Dec 5, 2023(See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07 New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22; ss by #13817-A, eff 12-5-23Former Division of Public Health Services
(a) DHHS/RHS shall license mobile medical services and clients of such services, limited to the following services:
- (1) Uptake, dilution, and excretion;
- (2) Imaging and localization;
- (3) Sealed sources in diagnosis; and
- (4) Certain in-vitro clinical or laboratory testing.
- (b) The client of the mobile medical service shall be licensed by DHHS/RHS if the client receives or possesses byproduct material to be used by a mobile medical service.
- (c) If the client is licensed, the letter shall document procedures for notification, receipt, storage, and documentation of transfer of byproduct material delivered to the client’s location for use by the mobile medical service.
- (d) A mobile medical service shall inform a responsible individual, such as a representative of management, a registered nurse in charge of the patient, or the registered nurse in charge of the nursing unit, who is on site at each client’s address of use at the time that radiopharmaceuticals are being administered.
Source. (See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07 New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22; ss by #13817-A, eff 12-5-23